Prospective study of TACE combined with sorafenib vs TACE combined with (125)I seed implantation in the treatment of hepatocellular carcinoma with portal vein tumor thrombus and arterioportal fistulas

PURPOSE: To compare the efficacy of TACE combined with sorafenib and TACE combined with (125)I seed implantation in the treatment of hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) combined with arterioportal fistulas (APFs), and discuss the efficacy and safety of TACE combined...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xiao-Hui, Yuan, Hang, Xia, Wei-Li, Zhang, Li-Lin, Li, Zhen, Cao, Guang-Shao, Li, Hai-Liang, Fan, Wei-Jun, Li, Hong-Le, Guo, Chen-Yang, Yao, Quan-Jun, Zhu, Wen-Bo, Hu, Hong-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581306/
https://www.ncbi.nlm.nih.gov/pubmed/36276129
http://dx.doi.org/10.3389/fonc.2022.977462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581306/
https://www.ncbi.nlm.nih.gov/pubmed/36276129
http://dx.doi.org/10.3389/fonc.2022.977462

Ejemplares similares